Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-12 | Amended | $29,185,713 | $150,004 | Equity Only | 06b | SEC link |
| 2024-11-12 | Amended | $29,035,709 | $949,996 | Equity Only | 06b | SEC link |
| 2023-11-15 | Amended | $28,085,713 | $2,999,995 | Equity Only | 06b | SEC link |
| 2022-01-11 | New | $25,085,718 | $25,085,718 | Equity Only | 06b | SEC link |
| 2017-08-22 | Amended | $10,006,317 | $6,500,001 | Equity Only | 06b | SEC link |
| 2016-08-26 | Amended | $3,506,316 | $500,000 | Equity Only | 06b | SEC link |
| 2014-07-22 | New | $3,006,316 | $3,006,316 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Justin Burns | Director |
| Jason R. Dinges | Director, Executive |
| Jeffrey L. Ives | Director |
| Martin Jefson | Director, Executive |
| Steven Kelly | Director, Executive |
| Kun Ping Lu | Director |
| Westley Nolin | Director |
| Stephanie O'brien | Director |